May 23, 2019 - Segerstrom Center for the Arts in Costa Mesa has announced its 2nd Annual Summer Jazz Series of free concerts, which will be held in its outdoor Julianne and George Argyros Plaza. Every Friday night June 7-Aug. 30 from 7-9 p.m., guests can show up for a free evening of a variety of styles of jazz […]
May 20, 2019 - JAZZ vs. PCRX: Which Stock Is the Better Value Option?
May 17, 2019 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
May 10, 2019 - The following slide deck was published by Jazz Pharmaceuticals plc in conjunction with this event.
May 10, 2019 - So far this earnings season, the going seems to be good for the medical sector. Let us take a glance at a few small drug companies, which are likely to beat on Q1 earnings.
May 10, 2019 - Jazz (JAZZ) is well positioned to outperform the market, as it exhibits above-average growth in financials.
May 08, 2019 - Jazz Pharmaceuticals (JAZZ) reports encouraging first-quarter 2019 earnings and revenues and maintains its guidance for 2019.
May 08, 2019 - The drugmaker reported strong revenue and earnings growth thanks largely to solid growth for narcolepsy drug Xyrem.
May 08, 2019 - JAZZ earnings call for the period ending March 31, 2019.
May 08, 2019 - Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ) Q1 2019 Results Earnings Conference Call May 7, 2019, 04:30 PM ET Company Participants Katherine Littrell - Head of Investor Relations Bruce Cozadd - Chairman